Essenz™ Perfusion System

About LivaNova

LivaNova PLC is a publicly traded medical technology company headquartered in London, UK, formed in 2015 from the merger of Sorin and Cyberonics. It operates in two core segments: Neuromodulation, with its Vagus Nerve Stimulation (VNS) Therapy for epilepsy and depression, and Cardiopulmonary, with heart-lung machines and perfusion systems for cardiac surgery. The company targets significant, underserved patient populations with chronic conditions, leveraging its established commercial footprint. Its strategy involves advancing its core platforms while exploring new indications and digital health integrations.

Therapeutic Areas